Typ : |
Noviny |
|
Výzkumné týmy : |
Callaghan - School of Pharmacy and Medical Sciences |
Autor : |
Sharley NA, Yu AMC, Williams DB. |
Titul : |
Stability of mixtures formulated from warfarin tablets or powder. |
Référence : |
J Pharm Pract and Res ; 37: 95-97. 2007 |
|
Úroveň důkazu : |
|
Fyzikální stabilita : |
|
Chemická stabilita : |
|
Jiné metody : |
|
Komentáře : |
|
Seznamy
Warfarin sodium
|
|
|
|
|
300 mg Coumadin® |
Sodík fosfát |
3000 mg |
Tragant |
4% 60 ml |
Sorbitol sirup |
5% 75 ml |
Methylparabenu |
240 mg |
Propylparaben |
60 mg |
Propylenglykol |
3 ml |
Destilovaná voda |
>> 300 ml |
|
20-24°C |
|
28 |
|
|
|
|
|
|
300 mg Marevan® |
Sodík fosfát |
3000 mg |
Tragant |
4% 60 ml |
Sorbitol sirup |
5% 75 ml |
Methylparabenu |
240 mg |
Propylparaben |
60 mg |
Propylenglykol |
3 ml |
Destilovaná voda |
>> 300 ml |
|
20-24°C |
|
28 |
|
|
|
|
Warfarin sodium clathrate
|
|
|
|
|
324.3 mg Warfarin sodium clathrate |
Sodík fosfát |
3000 mg |
Methylparabenu |
240 mg |
Propylparaben |
60 mg |
Propylenglykol |
3 ml |
Destilovaná voda |
>> 300 ml |
|
20-24°C |
|
28 |
|
|
|
|
|